Public annual accounts

Tistecoden financials

Name: Tistecoden financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Tistecoden, with comparable measures and links to available source documents.

Company overview

Registry number

0786456303

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Tistecoden

2025 versus 2024

Operating line: €60,816
EBITDA: €60,216
Total assets: €74,140
Equity: €4,000

EBITDA margin +99% · Equity ratio +5.4%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€60,816	€60,216	€74,140	€4,000	-
202431 Dec 2024	€74,065	€73,204	€130,872	€109,428	-

Gross margin as filed under the abbreviated schema. This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Tistecoden financials

Latest movements for Tistecoden

Filed annual accounts by fiscal year

Explore the underlying reports

Valuation